Sequential Measurements of Pentraxin 3 Serum Levels in Patients with Ventilator-Associated Pneumonia: A Nested Case-Control Study
Open Access
- 13 May 2018
- journal article
- research article
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2018, 1-8
Abstract
Purpose. The main purpose of this study was to investigate the dynamics of pentraxin 3 (PTX3) compared with procalcitonin (PCT) and C-reactive protein (CRP) in patients with suspicion of ventilator-associated pneumonia (VAP). Materials and Methods. We designed a nested case-control study. This study was performed in the Surgical Intensive Care Unit of a tertiary care academic university and teaching hospital. Ninety-one adults who were mechanically ventilated for >48 hours were enrolled in the study. VAP diagnosis was established among 28 patients following the 2005 ATS/IDSA guidelines. Results. The median PTX3 plasma level was 2.66 ng/mL in VAP adults compared to 0.25 ng/mL in non-VAP adults (). Procalcitonin and CRP levels did not significantly differ. Pentraxin 3, with a 2.56 ng/mL breakpoint, had 85% sensitivity, 86% specificity, 75% positive predictive value, and 92.9% negative predictive value for VAP diagnosis (AUC = 0.78). Conclusions. With the suspicion of VAP, a pentraxin 3 plasma breakpoint of 2.56 ng/mL could contribute to the decision of whether to start antibiotics.
Keywords
Funding Information
- Marmara University Clinical Research and Project Department (SAG-C-TUP-130515-0158)
This publication has 23 references indexed in Scilit:
- Pentraxin 3 in the assessment of ventilator-associated pneumonia: An early marker of severityHeart & Lung, 2013
- Pentraxin‐3: A novel biomarker for discriminating parapneumonic from other exudative effusionsRespirology, 2013
- Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumoniaClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Antibiotic strategies in severe nosocomial sepsisCritical Care Medicine, 2012
- Attributable Mortality of Ventilator-Associated Pneumonia: A Reappraisal Using Causal AnalysisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumoniaIntensive Care Medicine, 2008
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Alveolar and Serum ProcalcitoninAnesthesiology, 2002
- Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- APACHE IICritical Care Medicine, 1985